Title : Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine - Liu_2021_Cancer.Chemother.Pharmacol__ |
Author(s) : Liu D , Li X , Wang H , Dong M |
Ref : Cancer Chemother Pharmacol , : , 2021 |
Abstract : Liu_2021_Cancer.Chemother.Pharmacol__ |
ESTHER : Liu_2021_Cancer.Chemother.Pharmacol__ |
PubMedSearch : Liu_2021_Cancer.Chemother.Pharmacol__ |
PubMedID: 33586000 |
Liu D, Li X, Wang H, Dong M (2021)
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine
Cancer Chemother Pharmacol
:
Liu D, Li X, Wang H, Dong M (2021)
Cancer Chemother Pharmacol
: